InvestorsHub Logo
Followers 2
Posts 485
Boards Moderated 0
Alias Born 03/22/2012

Re: Lakersrback post# 14608

Monday, 01/07/2019 3:21:41 PM

Monday, January 07, 2019 3:21:41 PM

Post# of 27409
lakersrback, Dr. Chan spoke very well about the Greifswald sepsis study during his presentation today in San Francisco. The study with the worst cases of sepsis, refractory sepsis, which had not responded to any treatment and where the expected 28 day mortality was 0-10%. With treatment with Cytosorb, the 28 day mortality survival was an astonishing 41%! He stated that they were planning on a larger study to replicate the Greifswald findings. Apparently, Dr. Chan thinks more of the study than you do.

https://cytosorbents.com/data-presented-on-first-cytosorb-investigator-initiated-septic-shock-study/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News